跳至主要内容
临床试验/NCT03457116
NCT03457116已完成4 期

Narcotics vs Non-steroidal Ant Inflammatory Drugs Post-operative Analgesia in Outpatient Rhinoplasty

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2018年1月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
70
试验地点
1
主要终点
Average Post-Operative Day (POD) of Medication Cessation

研究概览

简要总结

The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This study will also evaluate potential contributing factors affecting the efficacy of these pain control methods. Patients will be randomized to receive either NSAIDs in the form of 400mg of Ibuprofen or Norco (hydrocodone 5mg- acetaminophen 325mg) to be used for post-operative pain. The study will then compare which is more effective in controlling post operative pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18-70 years old undergoing septorhinoplasty or rhinoplasty for either obstructive or aesthetic reasons. All approaches to rhinoplasty and surgical techniques utilized will be included. This will include patients that undergo additional procedures during the rhinoplasty including osteotomies, turbinate reduction, septoplasty, nasal valve repair and ear cartilage graft.

排除标准

  • Patients who undergo a rhinoplasty requiring a rib cartilage graft for the procedure as this is known to cause significant pleuritic chest pain.
  • Patients receiving functional endoscopic sinus surgery concurrently with the rhinoplasty will be excluded.
  • Patients with known history of gastrointestinal bleeds, peptic ulcer disease or who have other comorbidities that prevent them from taking NSAIDs.
  • Patients with a history of radiation, active head and neck malignancy or other pain disorders such as various rheumatologic diseases will be excluded to decrease confounding factors in the control of pain.

研究组 & 干预措施

Opiates

Active Comparator

Norco (hydrocodone 5mg- acetaminophen 325mg)

干预措施: Norco (Drug)

NSAIDS

Active Comparator

400mg of Ibuprofen

干预措施: NSAID (Drug)

结局指标

主要结局

Average Post-Operative Day (POD) of Medication Cessation

时间窗: Day 7

Self-reported via Post-Operative Pain Management Survey

Average Pain Score

时间窗: Day 7

Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)

次要结局

  • Number of Participants in NSAIDs Group Who Were Upgraded to Opiates Due to High Levels of Pain(Day 7)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验